Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Lipohypertrophy
ADR ID BADD_A06095
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.07      Skin and subcutaneous tissue disorders NEC
23.07.01      Lipodystrophies
23.07.01.005      Lipohypertrophy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.04      Lipid metabolism and deposit disorders NEC
14.08.04.009      Lipohypertrophy
Description A disorder characterized by hypertrophy of the subcutaneous adipose tissue at the site of multiple subcutaneous injections of insulin. [CTCAE]
MedDRA Code 10062315
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Buffalo hump | Lipohypertrophy | Dorsocervical fat enlargement
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00008Abacavir--
BADD_D00136Amprenavir--
BADD_D00174Asfotase alfa--
BADD_D00176Atazanavir--
BADD_D00306Budesonide--
BADD_D00490Clobetasol propionate0.001867%
BADD_D00586Darunavir--
BADD_D00603Delavirdine--
BADD_D00661Didanosine--
BADD_D00704Dolutegravir sodium--
BADD_D00749Efavirenz--
BADD_D00766Emtricitabine--
BADD_D00857Etravirine--
BADD_D00961Fosamprenavir calcium--
BADD_D01159Insulin (human)--
BADD_D01160Insulin aspart--
BADD_D01161Insulin degludec--
BADD_D01162Insulin detemir--
BADD_D01163Insulin glargine--
BADD_D01164Insulin glulisine--
BADD_D01165Insulin lispro--
BADD_D01242Lamivudine0.002226%
BADD_D01358Mecasermin--
BADD_D01550Nelfinavir mesylate--
BADD_D01557Nevirapine--
BADD_D01699Pegvisomant--
BADD_D01831Prednisolone0.000035%
BADD_D01834Prednisone0.000044%
BADD_D01906Raltegravir potassium--
BADD_D01940Rilpivirine--
The 1th Page    1 2    Next   Last    Total 2 Pages